Abiopharma

🔍 Xie Michael (Executive)

Company: Fortinet, Inc. (FTNT)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 2,763 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 9,929,637.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 2,242 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 9,931,879.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 1,300 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 9,933,179.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 3,184 shares of Common Stock at $86.29 per share (Direct)
  Date: 2026-05-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 9,929,995.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 190 shares of Common Stock at $87.0417 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 9,929,805.00 | transaction_form_type: 4 | Footnotes: F3, F4
• Sold 197 shares of Common Stock at $88.0859 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 9,929,608.00 | transaction_form_type: 4 | Footnotes: F3, F5
• Sold 2,028 shares of Common Stock at $89.1249 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 9,927,580.00 | transaction_form_type: 4 | Footnotes: F3, F6
• Sold 63 shares of Common Stock at $89.6086 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 9,927,517.00 | transaction_form_type: 4 | Footnotes: F3, F7
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: By trust | shares_owned_after: 19,825,614.00 | Footnotes: F8
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 5,513,505.00 | Footnotes: F9
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 5,513,505.00 | Footnotes: F10
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: By trust | shares_owned_after: 7,573,438.00 | Footnotes: F11
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: By trust | shares_owned_after: 7,573,438.00 | Footnotes: F12
• Sold 2,763 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 8,291.00 | transaction_form_type: 4 | Footnotes: F13, F1, F14, F15
• Sold 2,242 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 15,696.00 | transaction_form_type: 4 | Footnotes: F13, F1, F16, F15
• Sold 1,300 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 14,302.00 | transaction_form_type: 4 | Footnotes: F13, F1, F17, F15

Footnotes:

• F1: Vesting of restricted stock units ("RSUs") previously granted to the Reporting Person.
• F2: Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units.
• F3: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 10, 2024.
• F4: Represents the weighted average sale price. The lowest price at which shares were sold was $86.51 and the highest price at which shares were sold was $87.48. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the ranges set forth in footnotes (4), (5), (6) and (7) to this Form 4.
• F5: Represents the weighted average sale price. The lowest price at which shares were sold was $87.52 and the highest price at which shares were sold was $88.515.
• F6: Represents the weighted average sale price. The lowest price at which shares were sold was $88.52 and the highest price at which shares were sold was $89.51.
• F7: Represents the weighted average sale price. The lowest price at which shares were sold was $89.52 and the highest price at which shares were sold was $89.70.
• F8: These securities are held by the 2010 K.A. Family Trust dated May 3, 2010, for which the Reporting Person serves as a trustee.
• F9: Shares held directly by the KAXX Trust under The K.A. Children's Trust dated February 9, 2011, for which the Reporting Person serves as a trustee.
• F10: Shares held directly by the KAJJ Trust under The K.A. Children's Trust dated February 9, 2011, for which the Reporting Person serves as a trustee.
• F11: These securities are held by a grantor retained annuity trust for the benefit of the Reporting Person.
• F12: These securities are held by a grantor retained annuity trust for the benefit of the Reporting Person's spouse.
• F13: Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement.
• F14: 25% of the RSUs vested on February 1, 2024, and the remaining 75% of the RSUs will vest in equal installments on each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon settlement.
• F15: RSUs do not expire; they either vest or are canceled prior to the vesting date.
• F16: 25% of the RSUs vested on February 1, 2025, and the remaining 75% of the RSUs will vest in equal installments on each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting.
• F17: 25% of the RSUs vested on February 1, 2026, and the remaining 75% of the RSUs will vest in equal installments on each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon settlement.
• REMARKS: The number of shares reported as directly owned by the Reporting Person has been adjusted in connection with a reconciliation to the Reporting Person's shareholdings as reflected in the records of the Issuer's transfer agent.